REXO2 and COVID-19: Several candidates involved in inflammation and immune cell functions were identified, such as CTSC, CADM1, REXO2, and ZBTB16. Our findings implicate that the different immune response to the virus determined by host genetic diversity may be an important factor in determining the severity of COVID-19.